Filing Flows › P3 Health Partners (PIII) › Q2 2026 › vs Q1 2026
P3 Health Partners (PIII) Q2 2026 vs Q1 2026 (quarter over quarter)
P3 Health Partners's revenue fell $9K (0%) from $386M in Q1 2026 to $386M in Q2 2026. Operating margin 10.7% against 2.1% (+8.5 pts).
P3 Health Partners, Q2 2026: revenue $386M (+9% year over year), operating margin 10.7%, net earnings $7.4M, operating cash flow −$61.9M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Operating margin | 10.7% | 2.1% | +8.5 pts |
| Net margin | 1.9% | 0.3% | +1.6 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $386M | $386M | −$9K | 0% |
| Operating profit | $41.2M | $8.2M | $33.0M | +400% |
| Costs & expenses | $345M | $378M | −$33.0M | -9% |
| Pre-tax earnings | $16.9M | −$8.0M | $24.9M | — |
| Other expense, net | $24.3M | $16.2M | $8.1M | +50% |
| General & admin | $32.4M | $25.5M | $6.8M | +27% |
| Other operating costs | $313M | $352M | −$39.6M | -11% |
| Net earnings | $7.4M | $1.2M | $6.2M | +509% |
| Minority interests | $8.2M | $1.8M | $6.4M | +352% |
| Income tax | $1.3M | −$11.0M | $12.3M | — |
| Operating cash sources | $91.3M | $50.8M | $40.5M | +80% |
| Depreciation & amortization | $21.0M | $21.1M | −$30K | -0.1% |
| Share-based compensation | $866K | $1.1M | −$185K | -18% |
| Cash used in operations | $61.9M | $27.5M | $34.4M | +125% |
| Working capital & other | $91.3M | $50.8M | $40.5M | +80% |
Questions
How much did P3 Health Partners's revenue grow quarter over quarter in Q2 2026?
P3 Health Partners's revenue fell $9K (0%) from $386M in Q1 2026 to $386M in Q2 2026. Operating margin 10.7% against 2.1% (+8.5 pts).